Combining Ability Analysis for Yield and Its Component Traits in Rice (Oryza sativa L.)
Environment and Ecology · 2026-03 · 44 (1) · 151-158
DOI: 10.60151/envec/dito4023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environment and Ecology, 2026-03. Verfasst von C. Shobanadevi und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The present investigation was carried out to study general and specific combining ability of 11 parents and 28 hybrids of rice for their yield and component characters. The 28 hybrids derived from 7 lines and 4 testers in L × T matting design. Analysis of variance for combining ability revealed significant for all the characters. Variance due to SCA were greater than GCA for all the traits indicating preponderance of non-additive gene action for these traits. Among the parents ADT 43, TKM 13, ASD 16 among lines and ADT 37 and Tetep among testers were good general combiners for grain yield per plant and other component traits. Based on SCA effects crosses IR 50 × ADT 37, TKM 13 × Tetep, ADT 43 × Tetep, ADT 43 × IR 64, BPT 5204 × ADT 37, CR 1009 × ADT 37, CR 1009 × IR 64, ASD 16 × IR 64 and ASD 16 × IR 36 having positive and desirable SCA effects for yield and some of its component traits merit attention in breeding program for exploitation of hybrid cultivars.
Zitieren
APA
Shobanadevi, C., & Elangaimannan, R. (2026). Combining Ability Analysis for Yield and Its Component Traits in Rice (Oryza sativa L.). Environment and Ecology, 44(1), 151-158. https://doi.org/10.60151/envec/dito4023
Vancouver
Shobanadevi C, Elangaimannan R. Combining Ability Analysis for Yield and Its Component Traits in Rice (Oryza sativa L.). Environment and Ecology. 2026;44(1):151-158. doi:10.60151/envec/dito4023
BibTeX
@article{Shobanadevi2026,
author = {Shobanadevi, C. and Elangaimannan, R.},
title = {Combining Ability Analysis for Yield and Its Component Traits in Rice (Oryza sativa L.)},
journal = {Environment and Ecology},
year = {2026},
volume = {44},
number = {1},
pages = {151--158},
doi = {10.60151/envec/dito4023}
}
EUVIMED